Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.21.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Income Statement [Abstract]        
Research and development (“R&D”) expenses, net $ 6,608 $ 6,056 $ 16,102 $ 13,302
Amortization of intangible assets 380 380 1,139 1,139
General and administrative expenses 2,845 2,394 8,436 6,749
Operating loss 9,833 8,830 25,677 21,190
Financial expenses (income), net 188 5 76 (248)
Loss before tax 10,021 8,835 25,753 20,942
Tax expenses 10 16  
Net Loss $ 10,031 $ 8,835 $ 25,769 $ 20,942
Basic and diluted loss per share of Common Stock (in Dollars per share) $ 0.37 $ 0.38 $ 1.03 $ 0.91
Weighted average number of shares of Common Stock outstanding, basic and diluted (in Shares) 27,077,903 23,150,253 25,120,037 23,013,790